Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: The objective of this study is to systematically evaluate the efficacy of Extraperitoneal Cesarean Section (ECS) compared to Transabdominal Cesarean Section (TCS) in pregnant women, and to assess the differences in treatment outcomes between the two surgical approaches.

Approach And Techniques: We conducted an extensive literature search, pulling up the most recent findings from reputable sources like the Cochrane Library, PubMed, EMBASE, Google Scholar, and Web of Science, all the way up to October 2024. Our meta-analysis comprised seven randomized controlled trials. We followed a fixed-effects model for results with less heterogeneity and a random-effects model for those with more. We utilized Stata 18 to conduct data analysis. For continuous data, we computed weighted mean differences (WMD). For categorical data, we calculated odds ratios (OR). We also included 95% confidence intervals (CI) with all of our results. We also used the Cochrane Risk of Bias tool to check all of the randomized controlled trials (RCTs) for bias.

Results: This meta-analysis did not find any statistically significant differences between the two groups when it came to baseline factors such as Body Mass Index (BMI), gestational week, and history of cesarean section. Statistical analysis revealed no significant differences in surgical outcomes (i.e., time to delivery(WMD 2.25, 95% CI -0.29 to 4.79, p = 0.083), time to operation (WMD 3.11, 95% CI -2.96 to 9.18, p = 0.316), neonatal weight (WMD -62.25, 95% CI -152.37 to 27.87, p = 0.176), 1-min Apgar score (WMD 0.03, 95% CI -0.39 to 0.45, p = 0.897), 5-min Apgar score (WMD 0.09, 95% CI -0.07 to 0.24, p = 0.296), blood loss (WMD 36.41, 95% CI -21.51 to 94.32, p = 0.218), etc.) between the TCS and ECS groups. However, the ECS group had a significantly shorter hospital stay (WMD -0.51, 95% CI -0.89 to -0.13, p=0.009) and less reduction in hemoglobin level (WMD -0.23, 95% CI -0.39 to -0.07, p=0.004) compared to TCS.

Conclusion: To sum up, this meta-analysis shows that ECS may help with postoperative hemoglobin level changes and shortening hospital stays. ECS may improve recovery metrics without adversely affecting maternal or neonatal outcomes. This analysis provides valuable insights that can guide clinical decision-making, even though there was no statistically significant difference between the two surgical approaches in terms of delivery time, operative time, neonatal weight, Apgar scores, or blood loss.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12231665PMC
http://dx.doi.org/10.1186/s12893-025-02981-yDOI Listing

Publication Analysis

Top Keywords

randomized controlled
12
controlled trials
12
95%
9
transabdominal cesarean
8
wmd
8
neonatal weight
8
apgar score
8
score wmd
8
95% -039
8
blood loss
8

Similar Publications

Background: Children in low- and middle-income countries face obstacles to optimal language and cognitive development due to a variety of factors related to adverse socioeconomic conditions. One of these factors is compromised caregiver-child interactions and associated pressures on parenting. Early development interventions, such as dialogic book-sharing (DBS), address this variable, with evidence from both high-income countries and urban areas of low- and middle-income countries showing that such interventions enhance caregiver-child interaction and the associated benefits for child cognitive and socioemotional development.

View Article and Find Full Text PDF

Background: Various media are used to enhance public understanding about diseases. While mobile health apps are widely used, there is little proof for using such apps to raise awareness of skin diseases.

Objective: We intend to develop an app, called DEDIKASI-app, to raise awareness of skin diseases, including leprosy.

View Article and Find Full Text PDF

Importance: There is an unmet need for long-term, safe, effective, and hormone-free treatments for menopausal symptoms, including vasomotor symptoms (VMS) and sleep disturbances.

Objective: To evaluate the 52-week efficacy and safety of elinzanetant, a dual neurokinin-targeted therapy, for treating moderate to severe VMS associated with menopause.

Design, Setting, And Participants: OASIS-3 was a double-blind, placebo-controlled, randomized phase 3 clinical trial that was conducted at 83 sites in North America and Europe from August 27, 2021, to February 12, 2024, and included postmenopausal women aged 40 to 65 years who were seeking treatment for moderate to severe VMS (no requirement for a minimum number of VMS events per week).

View Article and Find Full Text PDF

Importance: Pregnant individuals with polycystic ovary syndrome (PCOS) present with a higher risk of pregnancy complications, including gestational diabetes, preeclampsia, and preterm birth. Myo-inositol supplementation may reduce these risks.

Objective: To determine whether daily supplementation with myo-inositol during pregnancy among individuals with PCOS reduces the risk of a composite outcome of gestational diabetes, preeclampsia, and preterm birth.

View Article and Find Full Text PDF

Importance: The cost-effectiveness of adding early in-bed cycling to usual physiotherapy among adults receiving mechanical ventilation in the intensive care unit (ICU) compared with usual physiotherapy alone is unknown.

Objective: To evaluate the cost-effectiveness of in-bed cycling plus usual physiotherapy compared with usual therapy alone in the Critical Care Cycling to Improve Lower Extremity Strength (CYCLE) randomized clinical trial.

Design, Setting, And Participants: This trial-based economic evaluation with a 90-day time horizon compared early cycling plus usual physiotherapy vs usual physiotherapy alone from a societal perspective.

View Article and Find Full Text PDF